Daniela Meyer

Identification of the first synthetic inhibitors of the type II transmembrane serine protease TMPRSS2 suitable for inhibition of influenza virus activation

Daniela Meyer, Frank Sielaff, Maya Hammami et al. · Biochemical Journal · 2013 · 137 citations

Biochemistry, Synthetic Virology, Natural Sciences +15

Matriptase, HAT, and TMPRSS2 Activate the Hemagglutinin of H9N2 Influenza A Viruses

Joanna Baron, Carolin Tarnow, Deborah Mayoli-Nüssle et al. · Journal of Virology · 2012 · 136 citations · Full text

Influenza A Viruses, Virus Structure, Viral Evolution +12

Hemagglutinin activating host cell proteases provide promising drug targets for the treatment of influenza A and B virus infections

Eva Böttcher‐Friebertshäuser, Yinghui Lu, Daniela Meyer et al. · Vaccine · 2012 · 46 citations

Vaccination, Host Cell Proteases, Immunology +8

Development of substrate analogue inhibitors for the human airway trypsin-like protease HAT

Frank Sielaff, Eva Böttcher‐Friebertshäuser, Daniela Meyer et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 45 citations · Full text

Protease Inhibitors, Asthma, Medicinal Chemistry +9

Treatment of canine generalized demodicosis with a ‘spot‐on’ formulation containing 10% moxidectin and 2.5% imidacloprid (Advocate^®, Bayer Healthcare)

Ralf S. Mueller, Daniela Meyer, Emmanuel Bensignor et al. · Veterinary Dermatology · 2009 · 39 citations · Full text